DMD Clinical Trials in United Kingdom

Families often search for Duchenne trials by country. Here you will find 14 studies with at least one listed site in United Kingdom, drawn from the curated DMD Warrior catalog.

10 trials are recruiting now. Site availability can change — verify locations on each study page and with the trial team before planning travel or screening visits.

Showing 14 clinical trials

A Gene Delivery Study to Evaluate the Safety and Expression of Elevidys in Participants Under the Age of Four With Duchenne Muscular Dystrophy (DMD) (ENVOL)

Active, Not RecruitingPhase 2Gene Therapy

Age

2–3 years

Sponsor

Hoffmann-La Roche

Countries

Belgium +5 more

NCT ID

NCT06128564

This information is provided for educational purposes only. Always consult the study investigators before making medical decisions.

Learn More

A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy (INSPIRE DUCHENNE)

Actively RecruitingPhase 1/2Gene Therapy

Age

0–17 years

Sponsor

Solid Biosciences

Countries

United States +3 more

NCT ID

NCT06138639

This information is provided for educational purposes only. Always consult the study investigators before making medical decisions.

Learn More

A Long-term Follow-up Study of Participants Who Received Elevidys in a Previous Clinical Study (EXPEDITION)

Enrolling by InvitationInterventionalGene Therapy

Age

2 years and older

Sponsor

Sarepta Therapeutics

Countries

United States +8 more

NCT ID

NCT05967351

This information is provided for educational purposes only. Always consult the study investigators before making medical decisions.

Learn More

A Gene Transfer Therapy Study to Evaluate the Safety and Efficacy of Elevidys in Non-Ambulatory and Ambulatory Participants With Duchenne Muscular Dystrophy (DMD) (ENVISION)

Active, Not RecruitingPhase 3Gene Therapy

Age

8 years and older

Sponsor

Sarepta Therapeutics

Countries

United States +13 more

NCT ID

NCT05881408

This information is provided for educational purposes only. Always consult the study investigators before making medical decisions.

Learn More

Satellos SAT-3247 Phase 2 Clinical Trial in Ambulatory Children with Duchenne Muscular Dystrophy (BASECAMP)

Actively RecruitingPhase 2Improving Muscle Growth & Protection

Age

7–9 years

Sponsor

Satellos Bioscience

Countries

United States +7 more

NCT ID

NCT07287189

This information is provided for educational purposes only. Always consult the study investigators before making medical decisions.

Learn More

BMN 351 Exon 51 Skipping Therapy for Duchenne Muscular Dystrophy: Phase 2 Extension Study

Enrolling by InvitationPhase 2Exon Skipping

Age

4 years and older

Sponsor

BioMarin Pharmaceutical

Countries

Italy +4 more

NCT ID

NCT07573631

This information is provided for educational purposes only. Always consult the study investigators before making medical decisions.

Learn More

BMN 351 Exon 51 Skipping Therapy for Duchenne Muscular Dystrophy: Phase 1/2 Clinical Trial

Active, Not RecruitingPhase 1/2Exon Skipping

Age

4–10 years

Sponsor

BioMarin Pharmaceutical

Countries

Italy +4 more

NCT ID

NCT06280209

This information is provided for educational purposes only. Always consult the study investigators before making medical decisions.

Learn More

ELEVATE-LTE: ENTR-601-44 & ENTR-601-45 Long-Term Duchenne Clinical Trial

Not Yet RecruitingPhase 2Exon Skipping

Age

4–20 years

Sponsor

Entrada Therapeutics

Countries

Belgium +4 more

NCT ID

NCT07682129

This information is provided for educational purposes only. Always consult the study investigators before making medical decisions.

Learn More

ENTR-601-45 Exon 45 Skipping Therapy for Duchenne Muscular Dystrophy: ELEVATE-45 Clinical Trial

Actively RecruitingPhase 1/2Exon Skipping

Age

4–20 years

Sponsor

Entrada Therapeutics

Countries

Belgium +4 more

NCT ID

NCT07038824

This information is provided for educational purposes only. Always consult the study investigators before making medical decisions.

Learn More

ENTR-601-44 Exon 44 Skipping Therapy for Duchenne Muscular Dystrophy: ELEVATE-44 Clinical Trial

Actively RecruitingPhase 1/2Exon Skipping

Age

4–20 years

Sponsor

Entrada Therapeutics

Countries

Belgium +3 more

NCT ID

NCT07037862

This information is provided for educational purposes only. Always consult the study investigators before making medical decisions.

Learn More

DYNE-251 Exon 51 Skipping Therapy for Duchenne Muscular Dystrophy: DELIVER Clinical Trial

Active, Not RecruitingPhase 1/2Exon Skipping

Age

4–16 years

Sponsor

Dyne Therapeutics

Countries

United States +8 more

NCT ID

NCT05524883

This information is provided for educational purposes only. Always consult the study investigators before making medical decisions.

Learn More

AOC 1044 Exon 44 Skipping Therapy for Duchenne Muscular Dystrophy: SAFARI44 Clinical Trial

Actively RecruitingPhase 3Exon Skipping

Age

6–16 years

Sponsor

Avidity Biosciences

Countries

Belgium +6 more

NCT ID

NCT07587242

This information is provided for educational purposes only. Always consult the study investigators before making medical decisions.

Learn More

WVE-N531 Exon 53 Skipping Therapy for Duchenne Muscular Dystrophy: Open-Label Extension Study

Enrolling by InvitationPhase 2Exon Skipping

Age

4–18 years

Sponsor

Wave Life Sciences

Countries

Jordan, United Kingdom

NCT ID

NCT07209332

This information is provided for educational purposes only. Always consult the study investigators before making medical decisions.

Learn More

WVE-N531 Exon 53 Skipping Therapy for Duchenne Muscular Dystrophy: FORWARD-53 Clinical Trial

Actively RecruitingPhase 1/2Exon Skipping

Age

4–18 years

Sponsor

Wave Life Sciences

Countries

United States +2 more

NCT ID

NCT04906460

This information is provided for educational purposes only. Always consult the study investigators before making medical decisions.

Learn More

About this trial list